Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

GLAUKOS CORPORATION

Filed by GLAUKOS CORPORATION.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 17, 2026
Income
Not reported
Expenses
$240,000.00
Filing UUID
552cce7b-1ef5-450a-a6a8-c5b10db8dc7b
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

MED · Medical/Disease Research/Clinical Labs

Legislation regarding FDA regulation of combination products

MMM · Medicare/Medicaid

H.R. 3514/ S. 1816 Improving Seniors Timely Access to Care Act of 2025 H.R. 2527 Early Detection of Vision Impairments for Children Act of 2025 CMS payment methodologies for OPPS/ASC

Literal federal measure citations: H.R. 3514, S. 1816, H.R. 2527

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.